Gemina Laboratories Ltd. (GLABF)
USD 0.44
(-2.91%)
USD 0.44
(-2.91%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 1.45 Million CAD | -22.33% |
| 2023 | 1.87 Million CAD | 32.03% |
| 2022 | 1.42 Million CAD | -43.8% |
| 2021 | 2.52 Million CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 1.45 Million CAD | -13.45% |
| 2024 FY | 1.45 Million CAD | -22.33% |
| 2024 Q2 | 1.84 Million CAD | -36.46% |
| 2024 Q3 | 1.68 Million CAD | -8.96% |
| 2024 Q1 | 2.9 Million CAD | 55.13% |
| 2023 Q3 | 1.89 Million CAD | -40.66% |
| 2023 Q2 | 3.19 Million CAD | 484.08% |
| 2023 Q1 | 547.51 Thousand CAD | -61.45% |
| 2023 FY | 1.87 Million CAD | 32.03% |
| 2023 Q4 | 1.87 Million CAD | -1.19% |
| 2022 Q2 | 1.63 Million CAD | -29.91% |
| 2022 Q1 | 2.32 Million CAD | -7.87% |
| 2022 FY | 1.42 Million CAD | -43.8% |
| 2022 Q4 | 1.42 Million CAD | -45.68% |
| 2022 Q3 | 2.61 Million CAD | 60.19% |
| 2021 Q4 | 2.52 Million CAD | 0.0% |
| 2021 FY | 2.52 Million CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 96.251% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | 79.829% |
| SQZ Biotechnologies Company | 107.18 Million USD | 98.641% |
| Evofem Biosciences, Inc. | 10.55 Million USD | 86.202% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 98.882% |
| Mesoblast Limited | 667.9 Million USD | 99.782% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -1912.42% |
| Genus plc | 1.02 Billion USD | 99.858% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -7.21% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -191.818% |
| Marizyme, Inc. | 22.01 Million USD | 93.385% |
| ContraFect Corporation | 20.67 Million USD | 92.958% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -132.263% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -273.057% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -281.051% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -1.694% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | 64.875% |
| MultiCell Technologies, Inc. | 126.22 USD | -1153669.609% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -54.976% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 98.867% |
| EV Biologics, Inc. | 431.71 Thousand USD | -237.327% |
| Q BioMed Inc. | 3.51 Million USD | 58.575% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 95.86% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -88.97% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -457.373% |
| Biomind Labs Inc. | 73.81 Thousand USD | -1872.782% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 462.85 Million USD | 99.685% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 95.148% |
| Skye Bioscience, Inc. | 11.94 Million USD | 87.804% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | 56.043% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | 46.973% |
| Arch Therapeutics, Inc. | 1.95 Million USD | 25.631% |
| IMV Inc. | 31.33 Million USD | 95.352% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -111.828% |
| Curative Biotechnology, Inc. | 2.6 Million USD | 44.058% |
| GB Sciences, Inc. | 103.44 Thousand USD | -1307.83% |
| Alpha Cognition Inc. | 2.45 Million USD | 40.612% |
| HST Global, Inc. | 1526.00 USD | -95331.717% |
| CSL Limited | 38.02 Billion USD | 99.996% |
| Halberd Corporation | 10.13 Thousand USD | -14274.573% |
| Enzolytics Inc. | 361.7 Million USD | 99.597% |
| Resverlogix Corp. | 8.11 Million USD | 82.054% |
| Affymax, Inc. | 7.44 Million USD | 80.434% |
| SYBLEU INC | 330.46 Thousand USD | -340.674% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | 22.45% |
| argenx SE | 4.54 Billion USD | 99.968% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 94.789% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 96.947% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -6292.555% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | 83.727% |
| AVAX Technologies, Inc. | 7.37 Million USD | 80.259% |
| Zenith Capital Corp. | 7410.00 USD | -19553.009% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.957% |
| Ember Therapeutics, Inc. | 184.00 USD | -791360.87% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -352.536% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -457.188% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 99.674% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -0.514% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 3.02 Million USD | 51.86% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 97.237% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -56.934% |
| BioStem Technologies, Inc. | 14.56 Million USD | 89.998% |
| ONE Bio Corp. | 70.08 Million USD | 97.922% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -2450.685% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -62942.771% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -47.402% |
| Agentix Corp. | 261.39 Thousand USD | -457.128% |
| LadRx Corporation | 2.3 Million USD | 36.899% |
| Cell Source, Inc. | 195.17 Thousand USD | -646.16% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -203.042% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -311.826% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -311.826% |
| NovAccess Global Inc. | 62.24 Thousand USD | -2239.494% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -127.667% |
| Itoco Inc. | 1.4 Million USD | -4.015% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -1422.406% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -1273.857% |
| Kadimastem Ltd | 2.3 Million USD | 36.795% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -1807.284% |
| CytoDyn Inc. | 11.13 Million USD | 86.923% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -918.583% |
| Mobile Lads Corp. | 52.00 USD | -2800453.846% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -8044.787% |
| Qrons Inc. | 420.00 USD | -346635.238% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -277.794% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -163.763% |
| Rebus Holdings, Inc. | 5000.00 USD | -29025.76% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -255.694% |
| International Stem Cell Corporation | 5.39 Million USD | 72.982% |
| Bioxytran, Inc. | 137.63 Thousand USD | -958.057% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 90.293% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 91.216% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -1743.403% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -68.42% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | 80.627% |
| Neutra Corp. | 2851.00 USD | -50979.902% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 95.506% |
| PureTech Health plc | 693.97 Million USD | 99.79% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | 81.957% |
| IXICO plc | 15.84 Million USD | 90.809% |
| IntelGenx Technologies Corp. | 8.28 Million USD | 82.416% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 98.591% |
| CSL Limited | 38.02 Billion USD | 99.996% |
| Cellectis S.A. | 333.99 Million USD | 99.564% |